Tobias Knapp joins as co-head of global firm’s New York transactional group | 2yrs
Life Sciences - Page 6
Covington counsels Biogen as Goodwin reps acquisition target Human Immunobiology Biosciences | 2yrs
Former FDA lawyers Jennifer Bragg and William McConagha move over in DC as Safehold CLO Douglas Heitner joins real estate team in New York | 2yrs
Office to handle outbound work for Japanese clients as UK firm aims to reach €1bn revenue in five years | 2yrs
The Law Over Borders Comparative Guide to Arbitration provides a comprehensive understanding of the current complexities of international arbitration. | 1yr
Led by respected life sciences litigator Siegmund Gutman, the team of 10 move over from Proskauer Rose | 2yrs
Düsseldorf local division orders US life sciences company Curio Bioscience to stop selling its products in Germany, France and Sweden in dispute with rival 10x Genomics | 2yrs
Transatlantic merger creates global giant with nearly 4,000 lawyers and $3.5bn revenue | 2yrs
UK pharmaceutical firm enters the fray in the battle over mRNA technology used to develop blockbuster vaccines | 2yrs
Greenberg counsels Ono in deal to expand Japanese group’s oncology portfolio and US presence | 2yrs
Women make up majority of round for firm in strong growth mode | 2yrs
Irena Royzman is fourth IP partner to join tech-focused firm this year | 2yrs
John Godfrey is the 12th Paul Weiss lawyer to decamp to Sidley in past 10 months | 2yrs
Deal second this month to see Freshfields advise acquisitive AstraZeneca | 2yrs
Tech-focused firm sees PEP grow 8.2% following almost 20% decline in 2022 | 2yrs
The top 25 US firm secures highly respected team of tech-focused IP litigators in Silicon Valley and Washington DC | 2yrs
Partner Robert Stroud joins from Florida firm Blalock Walters alongside counsel and an associate | 2yrs
Court rules specialist IP firms lack “legal interest” in transparency test case involving Ocado and Autostore | 2yrs
Team advising medtech company on dispute before USPTO helped found A&O’s West Coast practice | 2yrs
IP firm believe the newly established court is interpreting the public access rules too restrictively, looks to the EPO as a ‘paragon of openness’ in this area | 2yrs
Service aims to settle IP disputes in a single process avoiding the expense and complexity of litigation | 2yrs